Benefits of SGLT2 inhibitors combining with renin¿angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: A systemic review and meta-analysis Ting Liu; Rui Li; Xiaoxia Wang; Xingxing Gao; Xiaodong Zhang;